Kush Parmar Net Worth
Track Major Insider Updates On X/TwitterLast Updated: 6 days ago
Kush Parmar has an estimated net worth of at least $38.7 million*, as of April 15, 2026. They own 3.0 million shares of TRDA stock. They have sold 1.2 million shares of TRDA stock since 2021, for an estimated $-2.2 million.
Kush Parmar $TRDA SEC Form 4 Insider Trading
Kush Parmar has filed a total of 10 insider trades in $TRDA since 2021. Their most recent trade was a sale of 200,000 shares, made on Nov 14, 2025. Their largest trade was a purchase of 250,000 shares, made on Nov 02, 2021. We estimate that they now own 3.0 million shares of $TRDA, worth an estimated $40.8 million.
Insider Trading at $TRDA
There have been a total of 235 insider trades reported at $TRDA since 2021, with 2.2 million shares purchased and 1.3 million shares sold. The most active insider traders in $TRDA stock have been Dipal Doshi, Kory James Wentworth, and Nerissa Kreher. The most recent trade was a sale of 2,500 shares reported by KORY JAMES WENTWORTH (Chief Financial Officer), made on Apr 01, 2026.
History of Insider Stock Trades by Kush Parmar
| Company Ticker | Purchase / Sale | Shares | Date | Disclosed (EST) |
|---|---|---|---|---|
TRDA
|
Sale | 200,000 | Nov 14, 2025 | Nov. 18, 2025, 5:36 p.m. |
|
TRDA
|
Sale | 20,065 | Jul 09, 2025 | July 11, 2025, 5:27 p.m. |
|
TRDA
|
Sale | 6,935 | Jul 09, 2025 | July 11, 2025, 5:27 p.m. |
|
TRDA
|
Sale | 6,422 | Jun 30, 2025 | July 1, 2025, 8:33 p.m. |
|
TRDA
|
Sale | 55,735 | Jun 27, 2025 | July 1, 2025, 8:33 p.m. |
|
TRDA
|
Sale | 6,422 | Jul 01, 2025 | July 1, 2025, 8:33 p.m. |
|
TRDA
|
Sale | 18,578 | Jul 01, 2025 | July 1, 2025, 8:33 p.m. |
|
TRDA
|
Sale | 19,265 | Jun 27, 2025 | July 1, 2025, 8:33 p.m. |
|
TRDA
|
Sale | 18,578 | Jun 30, 2025 | July 1, 2025, 8:33 p.m. |
RLYB
|
Sale | 100,000 | Mar 07, 2023 | March 9, 2023, 5:39 p.m. |
|
RLYB
|
Sale | 50,329 | Jun 03, 2022 | June 7, 2022, 5:03 p.m. |
|
RLYB
|
Sale | 99,671 | Jun 03, 2022 | June 7, 2022, 5:03 p.m. |
|
RLYB
|
Sale | 66,447 | May 23, 2022 | May 25, 2022, 6:34 p.m. |
|
RLYB
|
Sale | 33,553 | May 23, 2022 | May 25, 2022, 6:34 p.m. |
|
RLYB
|
Sale | 139,539 | Feb 08, 2022 | Feb. 10, 2022, 7:22 p.m. |
|
RLYB
|
Sale | 70,461 | Feb 08, 2022 | Feb. 10, 2022, 7:22 p.m. |
VOR
|
Sale | 91,836 | Nov 16, 2021 | Nov. 18, 2021, 9:10 p.m. |
|
VOR
|
Sale | 238,870 | Nov 16, 2021 | Nov. 18, 2021, 9:10 p.m. |
|
TRDA
|
Purchase | 250,000 | Nov 02, 2021 | Nov. 4, 2021, 8 p.m. |
|
RLYB
|
Purchase | 615,384 | Aug 02, 2021 | Aug. 3, 2021, 8 p.m. |
$TRDA Executives and Stock Owners with Insider Trades
-
Dipal Doshi, President and CEO
-
Kory James Wentworth, Chief Financial Officer
-
Nerissa Kreher, Chief Medical Officer
-
Nathan J Dowden, Chief Operating Officer
-
Natarajan Sethuraman, Chief Scientific Officer
-
Natarajan Sethuraman, President, Research & Develop.
-
Nathan J Dowden, President & COO
-
Dipal Doshi, CEO
*This is only based off of information found in SEC filings, and may not reflect actual net worth. There may also be inaccuracies due to privately holdings filing errors, parsing errors, accidental double-counting of shares, incorrect classification of indirectly owned shares, sales prior to dataset start date, or any other number of issues.